The non-peptidic HIV protease inhibitor tipranavir and two synthetic peptidomimetics (TS98 and TS102) modulate Pneumocystis carinii growth and proteasome activity of HEL299 cell line

J Eukaryot Microbiol. 2006:53 Suppl 1:S144-6. doi: 10.1111/j.1550-7408.2006.00208.x.
No abstract available

MeSH terms

  • Animals
  • Antifungal Agents / pharmacology*
  • Cell Line
  • Coumarins / metabolism
  • HIV Protease Inhibitors / pharmacology*
  • Humans
  • Oligopeptides / metabolism
  • Pneumocystis carinii / drug effects*
  • Pneumocystis carinii / growth & development
  • Protease Inhibitors / pharmacology*
  • Proteasome Endopeptidase Complex / drug effects*
  • Proteasome Inhibitors
  • Pyridines / pharmacology*
  • Pyrones / pharmacology*
  • Rats
  • Sulfonamides

Substances

  • Antifungal Agents
  • Coumarins
  • HIV Protease Inhibitors
  • N-succinyl-leucyl-leucyl-valyl-tyrosyl-7-amino-4-methylcoumarin
  • Oligopeptides
  • Protease Inhibitors
  • Proteasome Inhibitors
  • Pyridines
  • Pyrones
  • Sulfonamides
  • Proteasome Endopeptidase Complex
  • tipranavir